The Europe HIV Injection Market would witness market growth of 17.4% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe HIV Injection Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $178.5 Million by 2029. The UK market is exhibiting a CAGR of 16.4% during (2023 - 2030). Additionally, The France market would experience a CAGR of 18.2% during (2023 - 2030).
Antiretroviral therapy (ART), the known treatment for HIV, entails the daily administration of a combination of HIV medications. ART can lower the risk of HIV transmission and help individuals with the virus live longer, healthier lives, although it cannot cure HIV. The development of effective treatments for HIV has been a major focus of research and development efforts in the pharmaceutical industry for several decades.
Antiretroviral therapy functions by inhibiting viral replication within the body, thereby facilitating immune system restoration and diminishing the likelihood of AIDS-associated complications. One of the key components of ART is the use of HIV injections, which are administered to patients either alone or in combination with other antiretroviral drugs.
According to the European Centre for Disease Prevention and Control, in 2022, 37 of the 49 countries in the Region, including 26 in the European Union/European Economic Area (EU/EEA), reported an increase in HIV diagnoses compared to 2021, with some countries reporting record-high numbers in a single year. Therefore, their demand will continue to grow in this region throughout the forecast period.
Free Valuable Insights: The Global HIV Injection Market will Hit USD 2.8 Billion by 2030, at a CAGR of 17.6%
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F.Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
Europe HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe HIV Injection Market, by Distribution Channel
1.4.2 Europe HIV Injection Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe HIV Injection Market by Distribution Channel
4.1 Europe Hospital Pharmacy Market by Country
4.2 Europe Drugs Stores & Retail Pharmacies Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe HIV Injection Market by Country
5.1 Germany HIV Injection Market
5.1.1 Germany HIV Injection Market by Distribution Channel
5.2 UK HIV Injection Market
5.2.1 UK HIV Injection Market by Distribution Channel
5.3 France HIV Injection Market
5.3.1 France HIV Injection Market by Distribution Channel
5.4 Russia HIV Injection Market
5.4.1 Russia HIV Injection Market by Distribution Channel
5.5 Spain HIV Injection Market
5.5.1 Spain HIV Injection Market by Distribution Channel
5.6 Italy HIV Injection Market
5.6.1 Italy HIV Injection Market by Distribution Channel
5.7 Rest of Europe HIV Injection Market
5.7.1 Rest of Europe HIV Injection Market by Distribution Channel
Chapter 6. Company Profiles
6.1 GlaxoSmithKline PLC (GSK)
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.1.5 SWOT Analysis
6.1 Gilead Sciences, Inc.
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expenses
6.1.4 SWOT Analysis
6.2 ImmunityBio, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 SWOT Analysis
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 SWOT Analysis
6.4 Theratechnologies Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Research & Development Expenses
6.4.4 SWOT Analysis
6.5 Viriom, Inc.
6.5.1 Company Overview
6.5.2 SWOT Analysis
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 SWOT Analysis
6.7 Brii Biosciences Limited
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.7.4 SWOT Analysis
6.8 Shionogi & Co., Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Research & Development Expenses
6.8.4 SWOT Analysis
6.9 Boehringer Ingelheim International GmbH
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional & Segmental Analysis
6.9.4 Research & Development Expenses
6.9.5 SWOT Analysis
TABLE 1 Europe HIV Injection Market, 2019 - 2022, USD Million
TABLE 2 Europe HIV Injection Market, 2023 - 2030, USD Million
TABLE 3 Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 4 Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 5 Europe Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe HIV Injection Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe HIV Injection Market by Country, 2023 - 2030, USD Million
TABLE 13 Germany HIV Injection Market, 2019 - 2022, USD Million
TABLE 14 Germany HIV Injection Market, 2023 - 2030, USD Million
TABLE 15 Germany HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 16 Germany HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 17 UK HIV Injection Market, 2019 - 2022, USD Million
TABLE 18 UK HIV Injection Market, 2023 - 2030, USD Million
TABLE 19 UK HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 20 UK HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 21 France HIV Injection Market, 2019 - 2022, USD Million
TABLE 22 France HIV Injection Market, 2023 - 2030, USD Million
TABLE 23 France HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 24 France HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 25 Russia HIV Injection Market, 2019 - 2022, USD Million
TABLE 26 Russia HIV Injection Market, 2023 - 2030, USD Million
TABLE 27 Russia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 28 Russia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 29 Spain HIV Injection Market, 2019 - 2022, USD Million
TABLE 30 Spain HIV Injection Market, 2023 - 2030, USD Million
TABLE 31 Spain HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 32 Spain HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 33 Italy HIV Injection Market, 2019 - 2022, USD Million
TABLE 34 Italy HIV Injection Market, 2023 - 2030, USD Million
TABLE 35 Italy HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 36 Italy HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 37 Rest of Europe HIV Injection Market, 2019 - 2022, USD Million
TABLE 38 Rest of Europe HIV Injection Market, 2023 - 2030, USD Million
TABLE 39 Rest of Europe HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 40 Rest of Europe HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 41 Key Information – GlaxoSmithKline PLC
TABLE 42 Key Information – Gilead Sciences, Inc.
TABLE 43 Key Information – ImmunityBio, Inc.
TABLE 44 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 45 Key Information – Theratechnologies Inc.
TABLE 46 Key Information – Viriom, Inc.
TABLE 47 Key information – AbbVie, Inc.
TABLE 48 Key Information – Brii Biosciences Limited
TABLE 49 Key Information – Shionogi & Co., Ltd.
TABLE 50 Key Information – Boehringer Ingelheim International GmbH
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe HIV Injection Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting HIV Injection Market
FIG 4 Porter’s Five Forces Analysis - HIV Injection Market
FIG 5 Europe HIV Injection Market share by Distribution Channel, 2022
FIG 6 Europe HIV Injection Market share by Distribution Channel, 2030
FIG 7 Europe HIV Injection Market by Distribution Channel, 2019 - 2030, USD Million
FIG 8 Europe HIV Injection Market share by Country, 2022
FIG 9 Europe HIV Injection Market share by Country, 2030
FIG 10 Europe HIV Injection Market by Country, 2019 - 2030, USD Million
FIG 11 SWOT Analysis: GlaxoSmithKline PLC
FIG 12 SWOT Analysis: Gilead Sciences, Inc.
FIG 13 SWOT Analysis: ImmunityBio, Inc.
FIG 14 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 15 SWOT Analysis: Theratechnologies Inc.
FIG 16 SWOT Analysis: Viriom, Inc.
FIG 17 Swot Analysis: AbbVie, Inc.
FIG 18 SWOT Analysis: Brii Biosciences Limited
FIG 19 SWOT Analysis: Shionogi & Co., Ltd.
FIG 20 SWOT Analysis: Boehringer Ingelheim International GmbH